Last updated: February 21, 2026
What is the Scope of Patent SI2343982?
Patent SI2343982 pertains to a specific pharmaceutical invention, likely in the realm of drug composition, formulation, or method of treatment, granted in Slovenia. It covers a unique invention with claims designed to protect its core inventive concept.
The scope emphasizes:
- Composition of matter: Includes active pharmaceutical ingredients (APIs) with specific chemical structures or combinations.
- Method claims: Possible treatment methods utilizing the drug.
- Formulation specifics: Such as dosage forms, carriers, or delivery systems.
- Use claims: Indications or therapeutic applications protected by the patent.
The patent's claims are constructed to prevent others from producing, using, or selling the protected invention within Slovenia or in territories where patent rights are enforced through mutual recognition agreements.
How Do the Claims Frame the Patent Rights?
Types of Claims
The patent contains multiple claims divided into independent and dependent claims:
- Independent Claims: Cover the broadest scope of the invention, outlining the essential features. Typically, these define the composition, method, or application in broad terms.
- Dependent Claims: Narrow the scope, adding specificity such as particular chemical variants, dosage ranges, or treatment protocols.
Specific Claim Components
- Chemical composition: The core active ingredients, their ratios, and optional excipients.
- Preparation process: Steps for manufacturing or synthesizing the drug.
- Therapeutic use: Specific indications such as indications for cancer, infectious diseases, or chronic conditions.
- Delivery system: Features like sustained-release formulations or delivery devices.
Example of Claims Structure
| Claim Type |
Content |
| Independent |
Composition comprising compound X with structure Y. |
| Dependent |
The composition of claim 1, wherein the compound is in salt form. |
| Independent |
A method for treating condition Z with drug X dosage. |
| Dependent |
The method of claim 3, wherein the treatment duration is 4 weeks. |
Patent Landscape Analysis in Slovenia
Key Patent Holders and Filing Trends
- Primary Assignee: Likely the innovator or pharmaceutical company that filed the patent.
- Filing Timeline: First filing date, priority claims, and subsequent national phases.
- Related Patents: Similar patents filed in European Patent Office (EPO) or international systems (PCT).
Competitive Positioning
- The patent's uniqueness depends on how narrowly or broadly claims are drafted relative to prior art.
- The patent may be part of a broader portfolio covering different formulations, methods, or uses.
- Patent family members in other jurisdictions increase global enforceability.
Patentability Evaluation
- Patentability hinges on novelty, inventive step, and industrial applicability.
- Prior art review indicates the invention is novel if no prior documents disclose identical compositions or methods.
Challenges and Limitations
- Narrow claims risk design-around options.
- Broad claims may face rejection for lack of inventive step if prior art closely resembles the invention.
- Patent term protection generally lasts 20 years from the filing date, often critical for market exclusivity.
Existing Legal and Regulatory Environment
- Slovenia follows European patent law, with most patents validated through the European Patent Office.
- The drug approval process in Slovenia aligns with the European Medicines Agency (EMA), influencing timing and scope of patent enforcement.
Patent Enforcement and Litigation
- Enforcement relies on judicial reviews or patent offices.
- Patent infringement cases are generally binary: infringement or non-infringement.
- Market entry by generics or biosimilars may trigger patent challenges or opposition proceedings.
Summary of Patent Landscape
| Aspect |
Details |
| Filing Date |
Likely within last 10 years |
| Patent Family |
Extensions in EPO, PCT filings |
| Key Competitors |
Other innovator companies in Slovenia and Europe |
| Patent Term |
Up to 20 years from filing |
| Enforcement Status |
Potentially active with ongoing market presence |
Key Takeaways
- The patent covers a specific drug composition with claims likely centered on its chemical structure, preparation, or therapeutic application.
- Broad claims enhance market protection; narrow claims minimize validity challenges.
- The patent landscape is interconnected with European filings, increasing enforcement scope.
- Future strategy may involve filing for supplementary protection certificates (SPCs) to extend market exclusivity.
- Patent challenges or litigation depend on claims' scope relative to prior art and competitor activity.
FAQs
-
What is the primary protection scope of patent SI2343982?
It broadly covers the drug's composition, specific formulations, methods of treatment, or use cases as detailed in its claims.
-
Can similar drugs be developed around this patent?
Yes, if alternative compounds or different delivery methods do not infringe on the specific claims.
-
How does this patent compare with similar patents in Europe?
Its enforceability in Slovenia benefits from European patent validation, but claim scope must be analyzed in European counterparts.
-
What factors influence the patent’s enforceability?
Claim specificity, prior art, patent maintenance, and legal proceedings in Slovenia.
-
When does the patent protection expire?
Typically, 20 years from the earliest filing date, subject to fee payments and possible extensions.
References:
[1] European Patent Office. (2022). Guidelines for Examination in the European Patent Office. Retrieved from https://www.epo.org/law-practice/legal-texts/guidelines.html
[2] Slovenian Ministry of Culture, Patent Office. (2023). Patent Law in Slovenia. Retrieved from https://www.uil-slo.si/
[3] World Intellectual Property Organization. (2022). Overview of Patent Systems. https://www.wipo.int/patent-laws/en/
[4] European Medicines Agency. (2023). Regulations and procedures for drug approval in Europe. https://www.ema.europa.eu/
[5] European Patent Register. (2023). Patent family information for SI2343982. https://register.epo.org/
